RecalledThisWeek Search
High risk Drugs & MedicationsClass II

Tri-Moxi Intraocular Injection Recall

Tri-Moxi+¿ (Triamcinolone 9mg/0.6mL, Moxifloxacin 0.6 mg/ 0.6 mL) Single-Use Intraocular Injection, Imprimis NJOF, LLC., 1705 Route 46 West

Updated December 18, 2025

Tri-Moxi (a steroid and antibiotic eye injection) is being recalled because it may contain glass-like particles that could damage the eye. If you received this injection, contact your doctor immediately.

Is the Imprimis NJOF, LLC recalled? Yes. This product was recalled by FDA on December 18, 2025. Details below.

What is recalled

Tri-Moxi (Triamcinolone 9mg/0.6mL, Moxifloxacin 0.6 mg/0.6 mL) Single-Use Intraocular Injection, made by Imprimis NJOF, LLC (NDC 71384-746-06).

Am I affected

You're affected if you received an intraocular injection of Tri-Moxi (NDC 71384-746-06) into your eye. Check with your eye doctor if you're unsure whether you received this product.

What to do right now

Contact your eye doctor or ophthalmologist immediately if you received this injection. Do not delay, glass-like particles in the eye require urgent medical evaluation.

The hazard

Presence of particulate matter - Glass like particles.

Brands affected

Imprimis NJOF, LLC
Source
FDA
Category
Drugs & Medications
Recall ID
fda-D-0251-2026
Classification
Class II
Recalled
December 18, 2025
Read the official notice

Get free recall alerts

New Drugs & Medications recalls, the moment they post.

Free forever. Unsubscribe anytime. We never sell your data.

More Drugs & Medications recalls